Optimisation Strategy for Emergency Tracheal Intubation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
This study has to objective to assess, in adults' patients needing tracheal intubation because of vital distress, the effect of a combined strategy to reduce intubation-related morbidity. This strategy will associate systematic use of rocuronium as paralyzing agent to facilitate tracheal intubation, bag face-mask ventilation before intubation and Gum Elastic Bougie (GEB) use.
Eligibility criteria
Qualifiers
Patient adult (≥ 18 years) presenting with vital distress requiring emergency tracheal intubation as assessed by the emergency physician in the out-of-hospital setting.
Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included.
Disqualifiers
Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist).
Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis).
Patient that are not members of a medical aid scheme (beneficiary or main member).
Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.
Trial design
Treatments tested in this trial
- Data patient
- Physical examination
- Rapid sequence intubation (RSI) : Rocuronium /Bag-mask ventilation /GEB
- Rapid sequence intubation (RSI) : Recommendations for emergency intubation
Treatment groups
1,500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov